Treatment efficacy of first-line immunotherapy in advanced esophageal small cell carcinoma: A real-world retrospective study
Esophageal small cell carcinoma remains a highly aggressive malignancy with poor prognosis in advanced stages. This retrospective real-world study suggests that first-line immunotherapy combined with chemotherapy may significantly improve progression-free survival in patients with advanced SCCE compared to chemotherapy alone.
Authors
- Nan Li (ORCID: https://orcid.org/0000-0003-4231-8853)
- Rui Zhang (ORCID: https://orcid.org/0000-0002-2559-6686)
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-02
- DOI
- https://doi.org/10.3389/fonc.2025.1630210
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00